Cargando…

Expression of PD-1 on CD4(+) T cells in peripheral blood associates with poor clinical outcome in non-small cell lung cancer

Recent success of using agents inhibiting the major immune check point, programmed cell death-1 (PD-1) pathway, offers a great promise for effective cancer therapy. Two blocking antibodies for PD-1, nivolumab and pembrolizumab have recently been approved for treating advanced recurrent non-small cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Hong, Liu, Xin, Zhang, Jianhong, Rice, Shawn J., Wagman, Matthias, Kong, Yaxian, Zhu, Liuluan, Zhu, Junjia, Joshi, Monika, Belani, Chandra P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302910/ https://www.ncbi.nlm.nih.gov/pubmed/27191652 http://dx.doi.org/10.18632/oncotarget.9316

Ejemplares similares

Trametinib with or without Vemurafenib in BRAF Mutated Non-Small Cell Lung Cancer
por: Joshi, Monika, et al.
Publicado: (2015)

Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer
por: Rice, Shawn J., et al.
Publicado: (2021)

Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia
por: Zhu, Liuluan, et al.
Publicado: (2017)

Afatinib for the treatment of metastatic non-small cell lung cancer
por: Joshi, Monika, et al.
Publicado: (2015)

EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancer
por: Rice, Shawn J., et al.
Publicado: (2019)

Peripheral tolerance induced by apoptotic cells and PD-1+ CD8 T cells
por: Kazama, Hirotaka, et al.
Publicado: (2012)

Early‐like differentiation status of systemic PD‐1(+) CD8 (+) T cells predicts PD‐1 blockade outcome in non‐small cell lung cancer
por: Khanniche, Asma, et al.
Publicado: (2022)

PD1(Hi) CD8(+) T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
por: Ma, Jiaqiang, et al.
Publicado: (2019)

PD-1(+)CD8(+) T Cells Proximal to PD-L1(+)CD68(+) Macrophages Are Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma Patients
por: Yang, Xiaobao, et al.
Publicado: (2023)

The effect of age on the clinical characteristics and innate immune cell function in the patients with abdominal sepsis
por: Lu, Jiaqi, et al.
Publicado: (2022)

Peripheral Polyfunctional PD1(+)CD8(+) T cells demonstrated strong immune protection in non‐small cell lung cancer
por: Liu, Yanyan, et al.
Publicado: (2022)

Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade
por: Bochem, Jonas, et al.
Publicado: (2019)

Guidance on the Clinical Management of Electronic Cigarette or Vaping-Associated Lung Injury
por: Rice, Shawn J., et al.
Publicado: (2020)

Expression of PD-1 by CD4(+)CD25(+)CD127(low) Treg cells in the peripheral blood of lung cancer patients
por: Zhong, AnYuan, et al.
Publicado: (2015)

Role of neutrophils in acute viral infection
por: Ma, Yuan, et al.
Publicado: (2021)

PD-1/PD-L1 blockades in non-small-cell lung cancer therapy
por: Jing, Wang, et al.
Publicado: (2016)

Retinoblastoma Is Characterized by a Cold, CD8+ Cell Poor, PD-L1− Microenvironment, Which Turns Into Hot, CD8+ Cell Rich, PD-L1+ After Chemotherapy
por: Miracco, Clelia, et al.
Publicado: (2021)

Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients
por: Arrieta, Oscar, et al.
Publicado: (2017)

A rewiring model of intratumoral interaction networks
por: Sang, Mengmeng, et al.
Publicado: (2019)

Decreased peripheral CD4(+)/CD8(+ )lymphocytes and poor prognosis in aged sepsis
por: Inoue, S, et al.
Publicado: (2012)

Predictable Roles of Peripheral IgM Memory B Cells for the Responses to Anti-PD-1 Monotherapy Against Advanced Non-Small Cell Lung Cancer
por: Xia, Liliang, et al.
Publicado: (2021)

Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients
por: Geng, Ruixuan, et al.
Publicado: (2023)

PD-1/PD-L1 Control of Antigen-Specifically Activated CD4 T-Cells of Neonates
por: Majer, Christiane, et al.
Publicado: (2023)

Decreased CD73+ Double-Negative T Cells and Elevated Level of Soluble CD73 Correlated With and Predicted Poor Immune Reconstitution in HIV-Infected Patients After Antiretroviral Therapy
por: Wang, Xinyue, et al.
Publicado: (2022)

Prognostic significance of peripheral CD8+CD28+ and CD8+CD28− T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy
por: Liu, Chao, et al.
Publicado: (2019)

EV PD-L1 Contributes to Immunosuppressive CD8(+) T Cells in Peripheral Blood of Pediatric Wilms Tumor
por: Zhang, Xiaoxue, et al.
Publicado: (2021)

TLR4 expression correlated with PD-L1 expression indicates a poor prognosis in patients with peripheral T-cell lymphomas
por: Zhao, Shu, et al.
Publicado: (2019)

High expression of PD-L1 mainly occurs in non-small cell lung cancer patients with squamous cell carcinoma or poor differentiation
por: LIU, LU, et al.
Publicado: (2023)

Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer
por: Yu, Kuan, et al.
Publicado: (2022)

High intensity interval exercise increases the frequency of peripheral PD-1+ CD8(+) central memory T-cells and soluble PD-L1 in humans
por: Wadley, Alex J., et al.
Publicado: (2020)

Sensory Adaptation in Naive Peripheral CD4 T Cells
por: Smith, Katy, et al.
Publicado: (2001)

Peripheral naïve CD8(+) T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study
por: Huang, Cheng, et al.
Publicado: (2022)

CD33 Expression on Peripheral Blood Monocytes Predicts Efficacy of Anti-PD-1 Immunotherapy Against Non-Small Cell Lung Cancer
por: Olingy, Claire, et al.
Publicado: (2022)

The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma
por: Li, Zhixuan, et al.
Publicado: (2020)

Downregulation of the PD-1/PD-Ls pathway in peripheral cells correlates with asbestosis severity
por: Qiu, Meihua, et al.
Publicado: (2021)

High CD133 Expression in the Nucleus and Cytoplasm Predicts Poor Prognosis in Non-Small Cell Lung Cancer
por: Huang, Minjie, et al.
Publicado: (2015)

BCL9 regulates CD226 and CD96 checkpoints in CD8(+) T cells to improve PD-1 response in cancer
por: Feng, Mei, et al.
Publicado: (2021)

PD-1/PD-L1 expression on CD(4+) T cells and myeloid DCs correlates with the immune pathogenesis of atrial fibrillation
por: Liu, Li, et al.
Publicado: (2015)

CXCR5(+)PD-1(+) follicular helper CD8 T cells control B cell tolerance
por: Chen, Yuhong, et al.
Publicado: (2019)

Restored CD8(+)PD-1(+) T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma
por: Zhu, Qian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3k7shj90dt9o6c5jv6kfjf87pb